About Grundium
Grundium is a company based in Tampere (Finland) founded in 2015 was acquired by EW Healthcare Partners in May 2022. Grundium has raised $2.37 million across 3 funding rounds from investors including European Union, EIC Fund and Ascend Capital Partners. Grundium offers products and services including Ocus® 20, Ocus® 40, and Ocus® M 40. Grundium operates in a competitive market with competitors including Akoya Biosciences, Scopio Labs, PreciPoint, Morphle and Optra SCAN, among others.
- Headquarter Tampere, Finland
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Grundium Oy
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$2.37 M (USD)
in 3 rounds
-
Latest Funding Round
$56.24 K (USD), Grant
Jun 30, 2020
-
Investors
European Union
& 3 more
-
Employee Count
Not available
-
Acquired by
EW Healthcare Partners
(May 05, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Grundium
Grundium offers a comprehensive portfolio of products and services, including Ocus® 20, Ocus® 40, and Ocus® M 40.
Provides fast scanning at 20x for histology workflows.
Offers high-resolution imaging at 40x for cytology applications.
Enables multi-slide scanning with 40x magnification for high-volume needs.
People of Grundium
Unlock access to complete
Funding Insights of Grundium
Grundium has successfully raised a total of $2.37M across 3 strategic funding rounds. The most recent funding activity was a Grant round of $56.24 thousand completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Grundium
Grundium has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union, EIC Fund and Ascend Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked | |
|
Capital is invested in early-stage disruptors for global ventures.
|
Locked | Locked | Locked | |
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Locked | Locked | Locked |
Investor details for Grundium
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Grundium
Investment portfolio details for Grundium
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Grundium
Detailed financials for Grundium
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Grundium Comparisons
Peer comparison for Grundium
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Grundium
Grundium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Akoya Biosciences, Scopio Labs, PreciPoint, Morphle and Optra SCAN, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of solutions for rapid proteomic profiling
|
|
| Locked | Locked | Locked |
Provider of computational imaging-based digital microscopes & image analysis tools
|
|
| Locked | Locked | Locked |
Digital microscopes and micro-positioning systems are developed.
|
|
| Locked | Locked | Locked |
Provider of robotic microtomes and digital pathology scanners. These devices automate tissue processing and slide scanning for anatomical pathology, dermatopathology, and hematology. The scanners offer high-resolution imaging and integrated workflows, facilitating efficient digital microscopy and telepathology applications. Various models cater to different throughput needs, from single-slide to high-volume batch processing. The company also offers AI-powered requisition data entry solutions.
|
|
| Locked | Locked | Locked |
Integrated digital pathology solutions.
|
Detailed competitors of Grundium
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Grundium
Complete news archive for Grundium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Grundium
Grundium was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Grundium is headquartered in Tampere, Finland.
Mika Kuisma is the current CEO of Grundium.
Grundium is a funded company, having raised a total of $2.37M across 3 funding rounds to date.
The company was founded in 2015 in Tampere, Finland, and operates within the medical devices sector, specializing in digital pathology tools. A flagship product, the Ocus microscope, is offered as a portable solution with automated X and Y stages, Z-focus capabilities, and high resolution imaging. Telepathology applications are supported through these devices, facilitating remote medical analysis in research settings.
Grundium's top competitors include Akoya Biosciences, Optra SCAN and Scopio Labs.
Grundium offers Ocus® 20, Ocus® 40, and Ocus® M 40.
Grundium has 4 investors. Key investors include European Union, EIC Fund, Ascend Capital Partners, and EW Healthcare Partners.